Anti-PD-1 immunotherapy
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Anti-PD-1 immunotherapy, covering 2022-11-15 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC [Phase 1]